Patrick G. Lepore, Director at VYNE Therapeutics Inc. (VYNE), bought 15,000 shares at $2.92 ($44K) on 2025-01-15, disclosed to the SEC on 2025-01-16.
Open-market purchase of $44k VYNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |
| LCI | BUY | 2022-02-10 | $44K | — | Filing → |